Rhevera Medical

Rhevera Medical Holdings, LLC (formerly Endologix Holdings, LLC) is a California-based, global medical device company dedicated to preserving and restoring the blood flow patients depend on. The Rhevera family of companies is focused on differentiated therapies for the interventional treatment of vascular disease, with an emphasis on the complex cases conventional approaches leave unresolved. Rhevera Medical is the parent company of Endologix LLC, which will continue to serve as the legal manufacturer of the company’s commercial products, including the DETOUR® System, the ALTO® Abdominal Stent Graft System, the AFX®2 Endovascular AAA System, and the Pounce™ Thrombectomy System. These products are designed to preserve and restore flow across a range of vascular diseases, from peripheral arterial disease to abdominal aortic aneurysms. To learn more about Rhevera Medical, please visit https://rheveramed.com.